INB-619, IN8bio’s novel gamma-delta ('γδ”) T cell engager through an Investigational New Drug ('IND”) application ...
The landscape of retirement planning may soon change profoundly. With the recent signing of an executive order aimed at allowing 401(k) plans to include alternative investments such as private equity, ...
KALA BIO, Inc. announces $10.75 million private placement to advance clinical development of KPI-012 for severe eye diseases. KALA Bio, Inc., a clinical-stage biopharmaceutical company focused on ...
Tenax Therapeutics, Inc. has announced a private placement financing agreement with RTW Investments that is expected to generate approximately $25 million in gross proceeds. This financing will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results